Alterity Therapeutics (ATHE) Total Debt (2011 - 2015)
Alterity Therapeutics (ATHE) posted quarterly Total Debt of $424.62 for Q4 2015, down 99.41% year-over-year from $71636.4 in Q4 2014, and up 4451.55% quarter-over-quarter from $9.33 in Q2 2015.
Alterity Therapeutics (ATHE) Total Debt (2011 - 2015) Analysis & Trends
Alterity Therapeutics' Total Debt history runs 5 years deep, the most recent figure standing at $424.62 for Q4 2015.
- In Q4 2015, Total Debt fell 99.41% year-over-year to $424.62; the TTM figure through Dec 2015 stood at $424.62 (down 99.41% YoY), while the FY2015 annual figure was $10.05, down 99.99% from the prior year.
- Total Debt for Q4 2015 stood at $424.62, up from $9.33 in the prior quarter.
- The five-year high for Total Debt was $16.9 million in Q4 2013, with the low at $9.33 in Q2 2015.
- The 5-year median for Total Debt is $338000.4 (2011), against an average of $2.0 million.
- The sharpest annual moves came in 2013 and 2015: Total Debt jumped 2061.15% in 2013, then tumbled 99.99% in 2015.
- Alterity Therapeutics' Total Debt stood at $336559.4 in 2011, then jumped by 132.82% to $783567.3 in 2012, then surged by 2061.15% to $16.9 million in 2013, then tumbled by 99.58% to $71636.4 in 2014, then plunged by 99.41% to $424.62 in 2015.
- Business Quant data shows ATHE's Total Debt at $424.62 in Q4 2015, $9.33 in Q2 2015, and $71636.4 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.34 Bn |
| 10 | Alterity Therapeutics | 48.08 Mn | 15.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 424.62 |
| Jun 30, 2015 | 9.33 |
| Dec 31, 2014 | 71,636.35 |
| Jun 30, 2014 | 91,755.89 |
| Dec 31, 2013 | 16.93 Mn |
| Jun 30, 2013 | 865,088.82 |
| Dec 31, 2012 | 783,567.34 |
| Jun 30, 2012 | 339,441.30 |
| Dec 31, 2011 | 336,559.41 |
| Jun 30, 2011 | 381,751.75 |